Xll TABLE OF CONTENTS 



CHAPTER XII. REACTION or THE HOST TO INFECTION. 



Facts and theories, 206 ; Physiological hyperplasia, 206 ; Phagocytosis and encapsu- 

 lation, 207; Chemical constitution of the cell, 207; Antitoxins, 208; Cell 

 receptor of first order, 209; Precipitins, 209; Receptor of second order, 210; 

 Agglutinins, 211; Phenomenon of agglutination, 211; Bactericidal substances, 

 212; Cytolysins, 213; Receptor of third order, 214; Amboceptor and comple- 

 ment, 214; Deviation of complement, 215; Fixation of complement, 216; 

 Opsonins, 217; Anti-aggressins, 218; Source and distribution of antibodies, 

 218; Allergy, 219. 



CHAPTER XIII. IMMUNITY AND HYPERSUSCEPTIBILITY. THEORIES 



or IMMUNITY. 



Immunity, 220; Natural immunity, 220; Immunity of species, 220. Racial im- 

 munity, 221; Individual variations, 221; Acquired immunity, 222; Active 

 immunity, 222. Passive immunity, 224. Combined active and passive 

 immunity, 225 ; Mechanisms of immunity, 225 ; Hypersusceptibility or Ana- 

 phylaxis, 226 ; Theories of immunity, 227. 



PART III. SPECIFIC MICRO-ORGANISMS. 



CHAPTER XIV. THE MOLDS AND YEASTS AND DISEASES CAUSED BY 



THEM. 



Mucors, 231; Aspergilli, 233; Penicillium crustaceum, 234; Claviceps purpurea, 

 234; Ergotism, 235; Botrytis bassiana, 235; Muscardine, 236; Oidium lactis, 

 236; Oidium albicans, 238; Thrush, 238; Achorion schoenleinii, 239; Favus, 

 239; Microsporon audouini, 241; Alopecia areata, 241; Microsporon furfur, 

 242 ; Tricophyton acuminatum, 242 ; Sporotrichum schenki, 242 ; Sporotri- 

 chum beurmanni, 244; Saccharomyces cerevisiae, 244; Blastomycetic derma- 

 titis, 244 ; Coccidioidal granuloma, 245. 



CHAPTER XV. TRICHOMYCETES. 



Actinomyces bovis, 246; Streptothrax madurae, 248; Mycetoma, 248; Cladothrix, 

 249 ; Leptothrix buccalis, 249. 



CHAPTER XVI. THE COCCACE^E AND THEIR PARASITIC 

 RELATIONSHIPS. 



Diplococcus gonorrheae, 250; Occurrence, 250., Culture, 250; Toxins, 253; Gonor- 

 rhea, 252; Specific diagnosis, 253; Prophylaxis, 253; Diplococcus meningi- 

 tidis, 253; Anti-meningococcus serum, 255; Quincke's puncture, 255; Exami- 



